navigating the fda decision on resmetirom: the road ahead
Published Streamed 5 months ago • 433 plays • Length 51:46Download video MP4
Download video MP3
Similar videos
-
10:26
fda approval of rezdiffra (resmetirom) for nash/mash treatment
-
5:14
introducing rezdiffra : the first fda approved drug for nash treatment
-
0:46
fda approves rezdiffra (resmetirom) for non-alcoholic fatty liver disease
-
2:17
resmetirom for nash with liver fibrosis | nejm
-
1:53
recently fda approved drug offers treatment for progressive liver disease
-
4:11
new fatty liver medicine fda approved | fatty liver treatment | rezdiffra resmetirom
-
1:19:57
ask the experts: nash and your diet
-
9:36
cirrhosis of liver: life expectancy by stage
-
19:29
promising phase 3 data for resmetirom suggests it may address ‘monumental’ unmet need in nash
-
5:17
5-minute check in: evaluating the use of resmetirom in patients with nash and liver fibrosis
-
7:52
#resmetirom : new fda approved drug for fatty liver
-
3:10
fda approves first drug for non-alcoholic steatohepatitis (nash): resmetirom explained │pharmacology
-
3:25
rezdiffra (resmetirom): the next big thing in liver disease treatment
-
3:10
understanding nash: disease progression and impact
-
8:44
naim alkhouri, md: resmetirom has been a “game changer” in mash since fda approval
-
28:34
mre for nafld and nash clinical trials
-
25:08
the road to comprehensive models of care for nafld - what are the endpoints? - jeffrey lazarus
-
58:17
ask the experts nash and clinical trial
-
6:45
best news on treatment of fatty liver today, 2022
-
24:41
perspectives & discussions: nafld and nash screening, diagnosis, and emerging treatments
-
1:00:19
s2-e30 - the global liver institute us nash action plan - what it is and how we all can help suppor